Two cases of DYNC1H1 mutations with intractable epilepsy.

Area of Science:

• Genetics
• Neuroscience
• Molecular Biology

Background:

• The DYNC1H1 gene encodes the heavy chain of cytoplasmic dynein 1, a crucial component of the dynein complex.
• Dominant DYNC1H1 mutations are associated with various neurological disorders, including Charcot-Marie-Tooth disease and intellectual disability with neuronal migration defects.

Observation:

• Two patients with de novo DYNC1H1 mutations presented with intractable epilepsy and severe intellectual disability.
• Patient 1 exhibited pachygyria and various seizure types, while Patient 2 had autism spectrum disorder and seizures without cortical malformations.
• Novel mutations identified were c.4691A>T, p.(Glu1564Val) in Patient 1 and c.12536T>C, p.(Leu4179Ser) in Patient 2.

Findings:

• The study identified two novel de novo mutations in the DYNC1H1 gene.
• Patient 2's mutation in the AAA6 domain is the second reported case without cortical malformations, suggesting this domain may have a limited role in neuronal migration.
• DYNC1H1 mutations can lead to a spectrum of neurological phenotypes, including epilepsy, intellectual disability, and autism spectrum disorder, with or without brain malformations.

Implications:

• These findings expand the known phenotypic spectrum associated with DYNC1H1 mutations.
• Understanding the role of specific DYNC1H1 domains, like AAA6, in neuronal development and function is crucial for diagnosing and potentially treating related disorders.
• Further research into DYNC1H1's function may reveal therapeutic targets for neurodevelopmental disorders.